The profitability of ADMA BIOLOGICS, INC. over the past 10 years
Chart ADMA BIOLOGICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →ADMA BIOLOGICS, INC. reported net income of $146.93M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $292.76M and operating income of $191.44M. It reported a profit in 2 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022 and 2023. Its highest net income in these years was $197.67M, in fiscal 2024.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $292.76M | $191.44M | $146.93M |
| 2024ended Dec 31, 2024 | $219.55M | $138.98M | $197.67M |
| 2023ended Dec 31, 2023 | $88.94M | $21.63M | -$28.24M |
| 2022ended Dec 31, 2022 | $35.27M | -$39.37M | -$65.9M |
| 2021ended Dec 31, 2021 | $1.17M | -$58.37M | -$71.65M |
| 2020ended Dec 31, 2020 | -$19.07M | -$64.91M | -$75.75M |
| 2019ended Dec 31, 2019 | -$10.16M* | -$41.42M | -$48.28M |
| 2018ended Dec 31, 2018 | -$25.21M | -$60.29M | -$65.74M |
| 2017ended Dec 31, 2017 | -$6.4M | -$39.31M | -$43.76M |
| 2016ended Dec 31, 2016 | $4.3M | -$17.33M | -$19.52M |
Fiscal years as ADMA BIOLOGICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADMA BIOLOGICS, INC.
- The revenue of ADMA BIOLOGICS, INC.
- The cash flow of ADMA BIOLOGICS, INC.
- The debt of ADMA BIOLOGICS, INC.
- All of ADMA BIOLOGICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what ADMA BIOLOGICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.